bosentan anhydrous has been researched along with Gangrene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, Y; Hatano, M; Ichimura, Y; Kawashima, T; Kinugawa, K; Kogure, A; Mitsui, H; Miyazaki, M; Sato, S; Sugaya, M; Takahashi, T; Takekoshi, T; Tamaki, Z; Taniguchi, T; Tomita, M; Yao, A | 1 |
| Dunne, J; Dutz, J; Ng, B; Shojania, K; van Eeden, S | 1 |
2 other study(ies) available for bosentan anhydrous and Gangrene
| Article | Year |
|---|---|
Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangrene.
Topics: Antihypertensive Agents; Bosentan; Female; Fingers; Gangrene; Humans; Middle Aged; Regional Blood Flow; Scleroderma, Diffuse; Skin Ulcer; Sulfonamides | 2011 |
Treatment of severe Raynaud's phenomenon with bosentan in a patient with systemic sclerosis.
Topics: Adult; Bosentan; Female; Fingers; Gangrene; Humans; Raynaud Disease; Scleroderma, Systemic; Sulfonamides | 2006 |